Mice transgenic for the human Huntington's disease mutation are not more susceptible to 3-nitropropionic acid than wild type mice

被引：0
|
作者：
Hickey, MA [1 ]
Morton, AJ [1 ]
机构：
[1] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2000年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
160P
引用
收藏
页码：U87 / U87
页数：1
相关论文
共 50 条
  • [21] The Latent Stem Cell Population Is Retained in the Hippocampus of Transgenic Huntington's Disease Mice but Not Wild-Type Mice
    Walker, Tara L.
    Turnbull, Geoff W.
    Mackay, Eirinn W.
    Hannan, Anthony J.
    Bartlett, Perry F.
    PLOS ONE, 2011, 6 (03):
  • [22] Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model
    Borlongan, CV
    Koutouzis, TK
    Freeman, TB
    Hauser, RA
    Cahill, DW
    Sanberg, PR
    BRAIN RESEARCH PROTOCOLS, 1997, 1 (03): : 253 - 257
  • [23] Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats
    Dhadde, Shivsharan B.
    Nagakannan, P.
    Roopesh, Marulasiddeshwara
    Kumar, S. R. Anand
    Thippeswamy, B. S.
    Veerapur, Veeresh P.
    Badami, S.
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 77 : 52 - 58
  • [24] Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation
    Morton, AJ
    Lagan, MA
    Skepper, JN
    Dunnett, SB
    JOURNAL OF NEUROCYTOLOGY, 2000, 29 (09): : 679 - 702
  • [25] Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease
    Shear, DA
    Dong, J
    Gundy, CD
    Haik-Creguer, KL
    Dunbar, GL
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (07): : 1217 - 1240
  • [26] The antioxidant effects of minocycline and tetracycline on 3-nitropropionic acid induced experimental Huntington's disease model
    Yuksel, Meral
    Sahin, Hulya
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 65 : S55 - S55
  • [27] Neuroprotective effect of pioglitazone against 3-nitropropionic acid induced animal models of Huntington's disease
    Kumar, P.
    Kalonia, H.
    Kumar, A.
    MOVEMENT DISORDERS, 2012, 27 : S57 - S57
  • [28] Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: A speculative explanation
    Borlongan, CV
    Nishino, H
    Sanberg, PR
    NEUROSCIENCE RESEARCH, 1997, 28 (03) : 185 - 189
  • [29] Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease
    Reynolds, DS
    Carter, RJ
    Morton, AJ
    JOURNAL OF NEUROSCIENCE, 1998, 18 (23): : 10116 - 10127
  • [30] Abnormal motor response to (+) methamphetamine in mice transgenic for the Huntington's disease mutation
    Carter, RJ
    Hickey, MA
    Mangiarini, L
    Mahal, A
    Bates, GP
    Morton, AJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 : 371 - 371
12345